• Metadoro
  • Productos
  • Noticias y análisis

Noticias y análisis

Consulte las perspectivas de mercado compartidas por los miembros de nuestra comunidad
26.01.2023
Top 5 perdedores de 2022: Consumo discrecional

En 2022, todo el sector de consumo discrecional, que incluye empresas que producen bienes no esenciales: automóviles, ropa, artículos de lujo, hoteles, restaurantes, etc., fue muy afectado. Cuando llegan tiempos difíciles, la gente sigue comprando comida, pero comienza a ahorrar en otras áreas. Los temores sobre la inflación y la recesión inminente provocaron el colapso del ETF XLY en casi 40% a finales de año. Sin embargo, tales reducciones a menudo brindan excelentes oportunidades de inversión, ya que es raro ver acciones de compañías icónicas como Nike, Toyota y Home Depot tan lejos de sus valores máximos. Los informes macroeconómicos recientes apuntan a que quizás los temores de una disminución en la demanda de los consumidores son demasiado pesimistas. Las ventas minoristas en EE.UU. durante la temporada navideña fueron bastante fuertes (según Mastercard, el gasto en los Estados Unidos aumentó 7.6% interanual entre el 1 de noviembre y el 24 de diciembre), y los empleadores siguen buscando nuevo personal. Tal dinámica favorece el aumento de los salarios y la preservación de la actividad de consumo.

21.04.2022
Tres acciones que están atrayendo la atención de los alcistas: Procter & Gamble

El informe financiero del famoso fabricante mundial de productos del segmento de consumo del primer trimestre de 2022 mostró todos los signos de un crecimiento estable de los ingresos, que alcanzaron los 19,38 mil millones de dólares, un 3,5% más de lo que esperaban los analistas de Wall Street, y también un 7% más del período correspondiente en 2021. Pero en comparación con la temporada prenavideña de fin de año, las cifras son, por supuesto, menores. Contrariamente a las afirmaciones de que las presiones de los precios de compra están perjudicando las ganancias de los productores, las ganancias por acción (EPS) aumentaron 7 centavos durante año a 1,33 dólares. Los suministros de productos médicos como Oral-B y Pepto-Bismol aumentaron un 13%.

Procter & Gamble elevó su pronóstico de ventas anual y confirmó que la demanda de productos de higiene y cuidado de la salud sigue siendo estable a pesar del aumento de los precios. "Orgánicamente, el crecimiento de los ingresos será del 6% al 7%", dijo la compañía, que está por encima del pronóstico de consenso de los analistas del 5,5%. Las acciones de Procter & Gamble subieron un 3% inmediatamente después de los datos trimestrales, deteniéndose en 88 centavos por debajo de su máximo de enero. Está claro que el precio no se mantendrá en los niveles actuales después de subir un 17,5% desde enero de 2021. Andre Schulten, vicepresidente de asuntos financieros de la compañía, dijo que espera una disminución de BPA de 1 centavo en el tercer trimestre debido al conflicto militar en Ucrania. En el cuarto trimestre, esta cifra puede disminuir en otros 4 centavos. El comentario sigue a la decisión de la compañía de dejar de invertir en Rusia y "reducir sustancialmente" su línea de productos, centrándose en productos de higiene, productos médicos y de cuidado personal. Rusia y Ucrania representan alrededor del 1,5% de todas las ventas de la empresa.

El negocio basado en la producción de productos de consumo diario suele ser más resistente durante una tormenta inflacionaria. Produce productos simples y necesarios que las personas han estado usando durante años y están acostumbrados a ellos. Es poco probable que las amas de casa renuncien a Pampers, Tampax o Always, y es poco probable que sus esposos que usan maquinillas para afeitar Gillette, estén listos para cambiar a otras marcas, especialmente cuando sus precios también están aumentando.

16.03.2023
¿Qué hará el S&P 500 después de caer a los 3400 puntos?

Los futuros sobre el índice de mercado amplio S&P 500 están resbalando cada vez más, mostrando que el intento de romper el límite superior del canal descendente a principios de febrero, aparentemente, no tuvo éxito. Y si es así, entonces es hora de considerar un plan aproximado para la caída del principal índice de referencia bursátil. En la mayoría de los casos, luego de que un instrumento financiero no logra romper un nivel importante, recibe un fuerte contraataque debido a la debilidad mostrada. Creo que en el caso de los futuros del S&P 500, esto significa un retorno lógico a la mitad del actual canal bajista en la zona de los 3400 puntos. Donde, como podemos ver, se ubica el primer nivel técnico muy fuerte. Tal caída en el índice de referencia bursátil estadounidense se correlaciona bien con la situación actual, cuando los mercados están temblando debido a la crisis bancaria en EE. UU. y Europa. Personalmente, prácticamente no tengo dudas sobre una caída a este nivel. Pero luego, las opciones demasiado polares y extremas sugieren una bifurcación en 3400 puntos.

Es posible que la situación se aclare durante la caída del mercado, pero hasta ahora lo máximo con lo que se puede contar vendiendo futuros del índice S&P 500, es su caída en el próximo mes y medio entre 12 y 14%.

19.01.2023
Top 5 líderes de crecimiento en 2022: la soja

En el verano de 2022, los futuros de soja alcanzaron su punto máximo, con un aumento de precio del 35% desde principios de año. Al analizar este instrumento, se debe tener en cuenta que la soja se usa en dos direcciones a la vez: no solo es una parte importante de la industria alimentaria (incluso se usa para alimentar el ganado), sino que también se utiliza para producir biodiesel para automóviles. En ese sentido, es muy similar al maíz, cuyos futuros también están en el mercado. Los principales impulsores de los aumentos de precios son la alta inflación, que eleva el costo de producción, la falta de fertilizantes y la incertidumbre relacionada con el clima en las regiones clave donde se cultiva la soja. En 2022, se cosecharon 163 millones de toneladas de soja en América Latina (principalmente en Brasil y Argentina), más que en los Estados Unidos, China e India. Varios brokers agrícolas esperan un nuevo aumento en la inflación de los alimentos. Se necesitan cosechas récord para satisfacer la demanda actual, mientras que un mal clima y los altos precios de la energía limitan significativamente la oferta.

22.03.2023
Gane dinero en el colapso del sistema bancario: JPMorgan Chase

Las acciones de JPM se cotizan 12% por debajo de sus máximos de febrero. Según los informes, la principal fuente de financiación de JPMorgan son las cuentas, por 2.34 trillones de dólares en total, mientras que las cuentas no aseguradas representaron solo $137.9 mil millones, o el 5.9% del total. Además, el banco cuenta con importantes reservas de liquidez ($540.5 mil millones) para reducir el riesgo de posibles problemas financieros. Vale la pena señalar el hecho de que JPMorgan administra sus activos de manera mucho más profesional que el Silicon Valley Bank en quiebra. Los portafolios de activos se pueden dividir en AFS (disponibles para la venta) y HTM (guardados hasta el vencimiento). Si la rentabilidad promedio de estos grupos en Silicon Valley Bank fue 1.51% y 1.63%, respectivamente, entonces en JPMorgan: 3.5% y 2.25%. Está claro que JPMorgan no es problemático y es incorrecto compararlo con los bancos regionales de EE. UU., y en el mercado lo entienden. Esto se ve confirmado por una caída bastante débil de las acciones de JPM en comparación con muchas otras acciones bancarias. En muchos sentidos, es precisamente por eso que no debemos esperar un crecimiento agresivo de las cotizaciones: la relación P/E es de 10.5, que está por debajo de los valores promedio de los últimos 10 años (11.5), pero por encima de la mediana del segmento (8.1). En otras palabras, JPM es de interés para los inversores a largo plazo que desean aumentar la participación de activos premium en su portafolio al precio más atractivo de los últimos seis meses.

B
Taiwan Semiconductor Continues to Do a Great Job

Shares of Taiwan Semiconductor (TSM), the world’s largest contract chipmaker, announced nearly 17% annual revenue growth 16.9% to an equivalent of $11.86 billion. The company's year-to-date sales production was up 33.8% vs the same 10-month period of 2024. This was also 11% above the prior month's achievement. TSM market value added more than 3% within the next trading day on the news, clearly poised to retake its all-time highs beyond $300 per unit, which were already more than $50 above this summer's highs near $250 and well above January's peaking price at $226.40. TSM is the most dedicated chip foundry if we mean it as a pure-play manufacturer, which is producing chips without designing its own. Still having a market share in the mid-60% range, it is a critical partner for most of the companies developing artificial intelligence (AI) chips. That's why TSM's outstanding achievements inspire optimism for all those investors who were seeking for any fresh driver to dispel doubts about the dominant AI-fuelled demand.

TSM is a key supplier to the AI darling NVIDIA (NVDA). The news helped NVIDIA shares to soar by 5.8% to $199.05 at Monday's closing to offset last week's correction. Just coincidentally or not, Nvidia CEO Jensen Huang said only several days ago that he had asked TSM for extra chip supplies. Other representatives of the chip segment also benefited a lot from this coordinated move up. Advanced Micro Devices (AMD) stock added about 4.5%, being only one step away from resurfacing $250, following dips below $225 last Friday. This significantly supported AMD positioning, which was exposed to increased volatility and contradictory expert estimates following the recent quarterly report.

No company is a separate entity in this industry anymore, because all of them are considered in close synergy by the investing minds. New price targets like $275 for AMD are now almost unquestioned, as well as $250 and higher for NVIDIA against the background of such a strong bullish power. For TSM itself, I would estimate the so-called measured move on charts, from a purely technical point of view, as $335 at least.

9
B
Eli Lilly Runs for Four-Digit Ballistic

Eli Lilly & Co added building a $3 billion pill facility in the Netherlands to investors' ever-growing expectations. The Dutch plant will meet weight-loss oral medicine demand for European consumers avoiding trans-border tariff and logistical headwinds. This came days after Lilly announced its more than $1.2 billion expansion in Carolina, Puerto Rico for its American customers and it wants to start two new US manufacturing sites in the coming months. LLY's manufacturing footprint already includes France, Ireland, Italy and Spain, facilities under construction in Ireland and Germany.

Expanding LLY's production capacities for its long-awaited Orforglipron-based pill is the best news of the week which already boosted the company's stock rally to as high at $955 only five weeks after I shared my personal "bet on at least a range from $925 to $950 per share, that is on a more than $100 of further rise in the coming months, of which at least half may occur within several weeks". And now everyone sees that the actual growth is even outpacing those daring projections for the world’s most valuable pharmaceutical company. Now there is a feeling that it runs to jump over the next mental barrier of $1000 per share, whereas previously it stopped at $972.5 about one year ago. This is even more likely given the accelerating momentum we have seen in the last month on charts. The future appendix area above historic record levels may resemble the same one near bottom prices in August.

Lilly clearly wins its competition in the field of its main Danish rival Novo Nordisk as the latter's products don't have obesity pills, only injection medication, which also reportedly may have side effects. Like a diplomat, Lilly's CEO David Ricks  mentioned the Dutch Leiden Bio Science Park was chosen due to its proximity to the European Medicines Agency and the availability of a skilled and multilingual workforce. Eli Lilly's new plant will also be for oral medications in cardiometabolic health, neuroscience, cancer treatment and immunology, based on cutting-edge paperless and AI-driven processes.

As for me, I prefer swimming, playing tennis and walking outdoors a lot to taking anti-obesity pills, but I will gladly buy myself some Eli Lilly stock to finance my healthy way of life with the money from their profits. And what is your life and investment choice?

88
The Leadership Inside the «Magnificent Seven” Is Breaking

Stunning results in Amazon's quarterly report as well as the South Korean much-hyped meeting between the U.S. and China leaders are still echoing through Wall Street, being the two major tech drivers till the middle of the current week even though both events took place last Thursday. So what if no written agreements were signed between U.S. president Donald Trump and China’s leader Xi Jinping. It's now clear to every investor that this round of tariff wars is over, with new outbursts being postponed for at least one year or so, as both sides respect each other's word. China will resume supplies of rare earth metals, so important to Trump. The arbitrarily introduced U.S. tariffs, including those related to the fentanyl, have been reduced. Port services and shipments of some of Nvidia's advanced chips outside the U.S. will be unblocked, even if latest Blackwell chips may remain banned for foreign customers. All of the above feeds the most favourable environment for further rallying in equity markets to unfold until Christmas time.

The details of the U.S. Federal Reserve's decision on October 29 are far less interesting, as its chair Jerome Powell's ritually flirtatious rhetoric about a supposedly undestined December rate cut faces the traders community's long and firmly betting on another inevitable slash in borrowing costs before the end of 2025. With U.S. jobs' relative weakness as a factor, all of this are medium-term expectations of the crowd and experts. Stock indexes moderate retreat on November 4 attributed to investors' worries about the health of the U.S. economy is still within the mainframe of this general concept. The pullback in the S&P 500 broad barometer came from the latest ISM manufacturing data, which showed that factory activity in the U.S. is still contracting for an eighth straight month, with a reading of 48.7 being below the 50-point mark to separate declining trends from growth indications. Testing the waters around 6,750 or some dips just below this level in terms of S&P 500 dynamics could even be worthwhile for attracting new purchases from local bottoms across a wider range of issuers.

Interestingly, the monetary easing with its cheaper U.S. Dollars funding haven't really helped many other companies aside from the AI-based surges and some of those firms who shared their most cool quarterly corporate news. Of course, there are also other beneficiaries aside prominent Amazon, which initially added about 13% to its market value last Friday, then pared this gain to nearly 10%, but only to jump another 4% on the first Monday of November. Even Apple Co, whose revenue exceeded the $100 billion milestone for the first time ever in the non-Christmas quarter and also surprisingly beat its Q2 number in the profit column by almost 18%, saw its share price rise solid within 3% to 5% but only in the first hours of Friday's trading session. Apple lost all those gains, sliding by more than $10 from its own fresh historical peaks above $277 per share. The bullish momentum has been lost amid Apple CEO's admission of continuing supply constraints and lag in rolling out all of its promised AI features globally. Anyway, Apple is still projecting 10% to 12% sales growth for the December quarter, potentially the biggest in its history. With the company successfully absorbing Trump tariffs, the market will probably respond sooner or later to clearly bullish fundamental signs, as it is based on a new AI-powered Siri on the horizon.

However, the leadership inside the so-called “Magnificent Seven” group of market cap trillionaires, including Apple, Alphabet, Amazon, Meta, Microsoft, Nvidia and Tesla, is now breaking. As for Amazon's Q3 results, we previously predicted that growing expectations of a potentially very strong holiday season with its Black Friday, Cyber Monday and then Christmas sales would largely offset softer growth in e-commerce businesses across the entire segment due to the lack of consumer confidence stemming from inflation and trade uncertainty, which, to a lesser extent, would also affect Amazon itself. But the core value of Amazon's report for investing minds is that it demonstrates the unwavering strength of cloud demand, which underpins Amazon's record-breaking performance. While e-commerce may be more or less vulnerable, cloud services and big data power will take care of everything. Every big company that taps into this cloud miracle just turns everything it touches into gold. Anyone who is outside this magic circle may fall behind as nothing is guaranteed for those who are not engaged enough into the cloud industry. A good message for many other AI-related giants, whose fortunes are built partially on cloud piles, including Microsoft and Google, which are next to Amazon in terms of cloud services' sales volume.

Meanwhile, Amazon Web Services (AWS), which is Amazon's cloud division, reported as much as 20% rise in Q3 sales compared with average expert estimates of an 18% increase. Amazon shrugged off a tough prior week when an extended outage at AWS felled many of the most popular websites and consumer apps. This provided its EPS (equity per share) soaring 24% above expectations as AWS typically accounts for only about 15% of Amazon’s total sales, but it makes up roughly 60% of the company’s total operating income. Despite Amazon has been the worst-performing stock among the “Magnificent Seven” in 2025, the explosive reaction to its Q3 report makes questionable which company could achieve the next $300-per-share barrier first, after Google-parent Alphabet nearly touched it in October, and it Amazon could be next rather than Apple, when firing on all cylinders. However, if all three behemoths leave this significant milestone behind their shoulders within the coming months, it seems that none of the adequate portfolio investors will be particularly upset.

141
B
Google Stock Blows the Roof

The success of Google earnings and the market's immediate response surprised even me, the most involved enthusiast of holding more Google shares in investment portfolio. Shares of Google-parent Alphabet (GOOG), which had already gained 14% since the beginning of the month on hot expectations, soared another 9% in extended trading hours on the night of October 30, nearly touching the $300 mark in pre-market trading. And they don't seem ready to slow down here for long. Perhaps a slight short-lived pullback could emerge, nothing above that.

The major reason behind this was that Google actually reported double-digit growth in every major business, beating preliminary expert estimates by far. Google's diluted EPS (earnings per share) was $2.87 vs much lower average forecast of $2.29, it's fantastic! The search engine-based plus cloud-related business together showed the first-ever quarter surpassing $100 billion in total sales. The so-called top-line number added 16% YoY to hit its record $102.35 billion vs average estimates of just $99.79 billion and against the giant's previous record achievement of $96.47 in Q4 2024. Purely search revenues rose 15% to $56.57 billion. The quarterly cloud-computing contribution surged 34% to $15.16 billion. Ad revenues from YouTube video platform gained 15% to $10.26 billion. Alphabet also said total ad sales are $74.18 billion in the quarter, up 13% YoY, with traffic acquisition costs rising modestly to $14.88 billion. Paid subscriptions, mostly consisting of cloud storage services and YouTube’s ad-free premiums, exceeded 300 million accounts. If these numbers are not enough for you, then the firm's capex (capital expenditures) increased to just under $24 billion during the period for ramping AI data centers and hardware. This will help to monetize AI technologies even better.

Despite headwinds like competitive steps by ChatGPT-maker OpenAI, which just launched its own browser, “our full stack approach to AI is delivering strong momentum... including the global rollout of AI Overviews and AI Mode in Search in record time,” said CEO Sundar Pichai. I have no words to add to these if I would like to justify why Google stock is in my personal top 5 picks to hold for the coming months.

316
1

Únete a nuestra comunidad

Comparta sus observaciones profesionales y aficionadas, intercambie experiencias, anticipe desarrollos

Categoría
Todo
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instrumentos
Autor
Todo
Metadoro
Colaboradores